Andere talen BIOLASE, Inc.

Aandelen

BIOL

US0909117022

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 10-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,1689 ^USD	-2,88%		+16,40%	-84,95%

01/04	BIOLASE, INC. : Een koopadvies van Ascendiant Capital	ZM
22/03	Wall Street zal vrijdag marginaal lager openen na toespraak van Powell, na donderdag recordhoogtes te hebben bereikt	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Wall Street Set to Open Marginally Lower Friday Following Powell Speech, After Hitting Record Highs Thursday	22/03
US Stock Futures Flat Ahead of Powell Speech After Reaching Record Highs on Thursday	22/03
Top Premarket Gainers	22/03
Biolase: Q4 Earnings Snapshot	21/03
BIOLASE, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	21/03
BIOLASE, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/03
BIOLASE TO REPORT FOURTH QUARTER AND FULL YEAR 2023 RESULTS ON MARCH 21, 2024	15/03
BIOLASE LAUNCHES STATE-OF-THE-ART ALL-TISSUE LASER SYSTEM TO ACCELERATE ADOPTION OF LASERS IN DENTISTRY	23/02
BIOLASE ANNOUNCES FIRST QUARTER 2024 WEBINAR SERIES 'LETS TALK DENTAL'	21/02
BIOLASE, INC. GRANTED EXTENSION BY NASDAQ TO REGAIN COMPLIANCE WITH THE STOCKHOLDERS EQUITY CONTINUED LISTING REQUIREMENT	15/02
Biolase Prices $7 Million Public Offering	13/02
BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024	30/01
BIOLASE, Inc. Provides Earnings Guidance for the Full-Year 2023	29/01
BIOLASE, Inc. Provides Earnings Guidance for the Year 2024	29/01
Dr. Carol Gomez Summerhays Intends to Resign as Member of the Board of Directors of Biolase, Inc	29/12
BIOLASE, Inc. Successfully Concludes Waterlase iPlus All Tissue Laser Trial	12/12
BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	06/12
Biolase, Inc. Enters into the Eleventh Amendment to Credit Agreement with SWK Funding LLC	17/11
BIOLASE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Biolase: Q3 Earnings Snapshot	09/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen BIOLASE, Inc.

Aandelen

BIOL

US0909117022

Andere talen

Filters